Stock Market News2 months NVS vs. LLY: Which Stock Is the Better Value Option? Zacks
NVS vs. LLY: Which Stock Is the Better Value Option?
Eli Lilly (LLY) · Pharmaceuticals
X15 hours NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here’s Why Zacks
X17 hours Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha
X17 hours Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks
X1 day Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks
X1 day Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks
X2 days Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks
X2 days Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist Yahoo Finance
X2 days Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Yahoo Finance
X2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance
X3 days Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks
X3 days Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha
X3 days Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks
X3 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X3 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks
X3 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance
X3 days Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha
X3 days Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks
X3 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance
X5 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance
X5 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance
X5 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance
X5 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily
X5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
X5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance
X6 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com
X6 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance
X6 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube
X6 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com
X6 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha
X6 days There’s a New Obesity King The Wall Street Journal
X6 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha
X6 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks
X6 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube
X6 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks
X6 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks
X6 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com
X6 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch
X7 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com
X7 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily
X7 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube
X7 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC
X7 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily
X7 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha
X1 week Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha
X1 week REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks
X1 week Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks
X1 week Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X1 week SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks
X1 week Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com
X1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.